Risks and limits of Longevity Labor

Longevity lab services (e.g., MyBody‑X DNA tests) promise personalized anti‑aging insights but carry several risks and limitations. First, many analyzed SNPs have small effect sizes and are derived from single‑population studies (e.g., rs2794720 in a Chinese cohort), limiting generalizability. Second, results can be misinterpreted as deterministic, whereas lifestyle factors (diet, exercise, sleep) dominate longevity outcomes. Third, biomarkers like ferritin may reflect inflammation rather than iron overload, requiring clinical follow‑up. Fourth, many products are marketing‑driven (e.g., Slim WeightLoss DNA test) and lack validated clinical recommendations. Fifth, genetic data privacy is a concern. In summary, these tests may serve as motivational tools but cannot replace medical advice. The evidence is mostly mechanistic or marketing‑based, not clinically strong.